Marketplace Tech Bytes: Week in Review — Investments flow into health tech, FDA approves modifying AI medical devices, and California’s AI insurance claim law
8 snips
Dec 13, 2024 Christina Farr, managing director with Manatt Health, dives into the transformative role of AI in healthcare. She discusses a surge in investments for AI-driven health tech startups, showcasing a rebound after 2023's slump. The FDA's new guidelines enabling software updates post-approval are explored as a pivotal step in tech innovation. Farr also highlights California’s groundbreaking law mandating human oversight for AI in healthcare, raising critical conversations about transparency and the ethical implications of automated decision-making.
AI Snips
Chapters
Transcript
Episode notes
Health Tech Funding Rebounds
- Health tech startups saw increased funding in 2024, rebounding from a downturn in 2023.
- This resurgence is largely driven by investor enthusiasm for artificial intelligence in healthcare.
Attract Funding with AI
- If you're seeking funding for a health tech startup, incorporate AI into your solution.
- Some investors prioritize AI above all else, potentially overlooking other valuable innovations.
FDA Adapts to AI
- The FDA issued new guidelines allowing modifications to AI algorithms in medical devices post-approval.
- This shift acknowledges the iterative nature of software development and promotes ongoing improvement in patient care.